FierceBiotech20d
Roche nets clearances for sexually transmitted infection tests at the point of care
According to Roche, that will allow the PCR-based platform and ... The cobas liat system. (Roche) “Rapid molecular point-of-care testing can revolutionise the clinical management of STIs in ...
Pharmabiz21d
US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels
US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...
manilatimes21d
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15-49 years old, most of which are asymptomatic.1 FDA CLIA-waived tests broaden access to ...
Hosted on MSN19d
Roche’s STI assay panels gain FDA 510(k) clearance and CLIA waiver
Leveraging gold-standard PCR technology, the cobas liat system claims to deliver outcomes ... “Rapid molecular point-of-care testing can revolutionise the clinical management of STIs in ...